Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine with Paclitaxel in Advanced Gastric Cancer
NCT03575637Phase 2Unknown
- Sponsor
- Peking University
- Start
- Jul 2018
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in gastric cancer (GC), sponsored by Peking University. Status: unknown.
02
Drugs
olanzapine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03575637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575637.